MSD and Lilly announce immuno-oncology collaboration
January 11, 2017Medical Communications, Research and Development Eli Lilly, Lartruvo, MSD, keytruda, lilly
MSD, known as Merck in North America, and Eli Lilly have announced the expansion of their existing immuno-oncology collaboration. The …
MPS extends its range of child resistant packaging
January 11, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Multi Packaging Solutions
MPS has extended its range of child resistant packs. These patented designs offer maximum flexibility and can be customised to …
MSD looks to jump the gun with combination immunotherapy application
January 11, 2017Research and Development, Sales and Marketing AstraZeneca, BMS, MSD, Roche, immunotherapy, keytruda
MSD, known as Merck in North America, has launched a bold move by filing Keytruda, and being accepted, for Priority …
Philips and Illumina partner up for integrated genomics oncology solution
January 11, 2017Research and Development Illumina, Philips, oncology
Technology firm Philips and biotech Illumina have announced they are to partner up in collaboration which plans to marry the …
New formulary ‘bank’ to aid research into combination therapies
January 11, 2017Medical Communications, Research and Development 21st Century Cures Act, Bristol-Myers Squibb, Eli Lilly, Joe Biden, Obama, bristol myers-squibb, combination therapy
As part of the wider ‘cancer moonshot’ initiative, confirmed by the signing of the 21st Century Cures Act by Obama, …
Daiichi pulls out of India with closure of 170-strong R&D plant
January 11, 2017Manufacturing and Production, Research and Development Daiichi Sankyo, Ranbaxy, Sun Pharma
Japanese pharma firm Daiichi Sankyo has announced its intention to close its R&D centre in Gurgaon, India, a step in …
FDA warns that St. Jude’s heart devices could be hacked
January 11, 2017Medical Communications, Research and Development Abbott, Muddy waters, St. Jude, medsec
The FDA regulator has publicly announced that there are safety issues with certain of St. Jude’s medical devices, including cardiac …
Woodley Equipment Company Exhibiting at Summit for Clinical Ops Executives (SCOPE)
January 10, 2017Medical Equipment Supplier, SCOPE2017
Woodley Equipment Company Exhibiting at Summit for Clinical Ops Executives (SCOPE) Woodley Equipment Company is exhibiting at Summit for Clinical …
SHL brings innovation to Pharmapack Europe 2017
January 10, 2017Manufacturing and Production, Research and Development, Sales and Marketing auto injector, connectivity, delivery devices, smart packaging
As a forward-looking company with extensive knowledge and experience, SHL delivers solutions for today on the path to tomorrow. This …
Research finds cancer cells spread even before tumour development
January 10, 2017Manufacturing and Production, Research and Development Cancer
Studies at the Icahn School of Medicine in New York City and the University of Regensburg in Germany have found …
Egalet gains FDA approval for difficult to abuse painkiller
January 10, 2017Manufacturing and Production, Research and Development, Sales and Marketing Arymo ER, Egalet Corp, FDA
Egalet has gained FDA approval for Arymo ER, a long-acting opioid painkiller that is made to be difficult to breakdown. …
Valeant to sell cancer business to Sanpower for $820m
January 10, 2017Manufacturing and Production, Sales and Marketing Dendreon, Sanpower, Valeant
Valeant Pharmaceuticals has announced it is to sell its cancer business Dendreon to Chinese firm Sanpower in a deal worth …
Alzheimer’s drug could point to future of dentistry
January 10, 2017Manufacturing and Production, Research and Development Alzheimer's drug, Dentistry, dentine, dentist, enamel, teeth
Researchers at King’s College London have discovered a novel use of a drug to treat Alzheimer’s disease, finding that the …
Takeda to acquire Ariad in $5.2 billion deal
January 9, 2017Manufacturing and Production, Sales and Marketing Ariad, Takeda
Takeda has acquired US drug maker, Ariad Pharmaceuticals, in a deal worth $5.2 billion. Takeda has been looking to bolster …
Abbott completes $25 billion deal for St. Jude
January 9, 2017Sales and Marketing Abbott, St. Jude
It has been announced that the Federal Trade Commission has approved Abbott Laboratories acquisition of St. Jude Medical for $25 …
Pharmafile.com’s top ten most popular articles of 2016
January 9, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
Happy New Year from us here at Pharmafocus! As we leave 2016 behind, take a look at ten of its …
Amgen and Immatics enter $1bn immuno-oncology partnership
January 9, 2017Research and Development, Sales and Marketing Amgen, immatics, immunotherapy
Amgen has announced it is to join forces with cancer immunotherapy biotech Immatics Biotechnologies in a partnership potentially worth over …
Merrimack sells off drug for $1 billion and cuts workforce by 80%
January 9, 2017Sales and Marketing Onivyde, ipsen, merrimack
Ipsen has announced the agreement to acquire oncology assets from Merrimack Pharmaceuticals, most notably the pancreatic cancer drug Onivyde, in …
Roche’s Tecentriq scores another bladder cancer Priority Review
January 9, 2017Sales and Marketing Roche, bladder cancer, tecentriq
Roche has announced that its immunotherapy drug Tecenetriq (atezolizumab) has been awarded Priority Review by the FDA for the treatment …
Targovax promotes new CFO
January 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targovax
Erik Digman Wiklund has been named as the new chief financial officer (CFO) of Norwegian biotech Targovax, replacing Oystein Soug …
